Sign In
Buy TVRD
Tvardi Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 5.06M and sold 631.32K TVRD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 5.06M shares |
| ● Sell | 631.32K shares |
|
98% Buy Activity
Weak Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 09, 2026 Buy |
Shiff Susan Ph.d. Director |
6 000 Value: $16.7K |
||
|
Jun 09, 2026 Buy |
Smith Cynthia Director |
6 000 Value: $16.7K |
||
|
Jun 09, 2026 Buy |
Shah Sujal Director |
6 000 Value: $16.7K |
||
|
Jun 09, 2026 Buy |
Hall Wallace L Jr Director |
6 000 Value: $16.7K |
||
|
Jun 09, 2026 Buy |
Wyzga Michael S Director |
6 000 Value: $16.7K |
||
|
Jan 29, 2026 Buy |
O'brien Stephen Paul Principal Accounting Officer |
15 000 Value: $58.5K |
||
|
Jan 29, 2026 Buy |
Conn Avi Daniel Chief Financial Officer |
45 000 Value: $175.5K |
||
|
Jan 29, 2026 Buy |
Kauh John Saewook M.d. Chief Medical Officer |
45 000 Value: $175.5K |
||
|
Jan 29, 2026 Buy |
Alibhai Imran Nizamudin Chief Executive Officer |
115 000 Value: $448.5K |
||
|
Dec 16, 2025 Buy |
O'brien Stephen Paul Principal Accounting Officer |
4 000 Value: $16.8K |
||
|
Dec 16, 2025 Buy |
Kauh John Saewook M.d. Chief Medical Officer |
17 500 Value: $73.5K |
||
|
Dec 16, 2025 Buy |
Conn Avi Daniel Chief Financial Officer |
17 500 Value: $73.5K |
||
|
Dec 16, 2025 Buy |
Alibhai Imran Nizamudin Chief Executive Officer |
47 500 Value: $199.5K |
||
|
Jul 07, 2025 Sell |
Tweardy Samuel David 10 Percent Owner |
315 658 Value: $0 |
||
|
Jul 07, 2025 Sell |
Tweardy Samuel David 10 Percent Owner |
315 658 Value: $0 |
||
|
Apr 17, 2025 Buy |
Larson Jeffrey Leroy SVP, Research & Development |
10 820 Value: $184.4K |
||
|
Apr 17, 2025 Buy |
O'brien Stephen Paul Principal Accounting Officer |
7 213 Value: $122.9K |
||
|
Apr 17, 2025 Buy |
Chen Yixin Vp, Chem, Mfg And Ctrls |
7 213 Value: $122.9K |
||
|
Apr 17, 2025 Buy |
Conn Avi Daniel Chief Financial Officer |
43 547 Value: $742.0K |
||
|
Apr 17, 2025 Buy |
Kauh John Saewook M.d. Chief Medical Officer |
36 210 Value: $617.0K |
||
|
Apr 17, 2025 Buy |
Alibhai Imran Nizamudin Chief Executive Officer |
182 320 Value: $3.11M |
||
|
Apr 17, 2025 Buy |
Shiff Susan Ph.d. Director |
12 000 Value: $204.5K |
||
|
Apr 17, 2025 Buy |
Wirk Shaheen Director |
12 000 Value: $204.5K |
||
|
Apr 17, 2025 Buy |
Wyzga Michael S Director |
12 000 Value: $204.5K |
||
|
Apr 17, 2025 Buy |
Smith Cynthia Director |
12 000 Value: $204.5K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
